tiprankstipranks
Advertisement
Advertisement
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
PremiumCompany AnnouncementsScancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
4M ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
Premium
Company Announcements
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
5M ago
Scancell Holdings Successfully Passes AGM Resolutions
Premium
Company Announcements
Scancell Holdings Successfully Passes AGM Resolutions
5M ago
Scancell Holdings’ Earnings Call: Strategic Growth Amid Financial Challenges
PremiumCompany AnnouncementsScancell Holdings’ Earnings Call: Strategic Growth Amid Financial Challenges
7M ago
Scancell Holdings Reports Positive Trial Results and Strategic Developments
Premium
Company Announcements
Scancell Holdings Reports Positive Trial Results and Strategic Developments
7M ago
Scancell Holdings to Announce Year-End Results and Business Update
Premium
Company Announcements
Scancell Holdings to Announce Year-End Results and Business Update
7M ago
Scancell Advances iSCIB1+ Immunotherapy in Phase 2 Melanoma Study
PremiumCompany AnnouncementsScancell Advances iSCIB1+ Immunotherapy in Phase 2 Melanoma Study
9M ago
Scancell Holdings Sees Increased Investment from Vulpes Testudo Fund
Premium
Company Announcements
Scancell Holdings Sees Increased Investment from Vulpes Testudo Fund
11M ago
Scancell Partners with NHS to Fast-Track Melanoma Vaccine Access
Premium
Company Announcements
Scancell Partners with NHS to Fast-Track Melanoma Vaccine Access
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100